The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

Sigachi Industries Limited (SIL) is one of the largest manufacturers of microcrystalline cellulose (MCC) worldwide. It ...

Bulk drugs or active pharmaceutical ingredients (APIs) are the building blocks of medicines responsible for their therapeutic ...

Brittany and Patrick Mahomes have welcomed a baby girl! Golden Raye Mahomes arrived on Sunday, Jan. 12, 2025, according to an Instagram post the parents shared Monday. The Kansas City Chiefs ...

At Solar-Shield, we leverage decades of expertise to enhance educational buildings with cutting-edge external shading solutions. Founded by Paul Morris, a third-generation blind maker with over 35 ...

Sterling falls sharply versus yen BoJ to debate raising rates next week Bank of England expected to ease monetary policy Analysts say could be too soon to expect sterling rebound Jan 16 (Reuters ...

Arsenal’s season was rocked on Sunday afternoon when Gabriel Jesus was stretchered off with a nasty-looking injury. It was confirmed on Tuesday that Jesus will sit the rest of the season out ...

Golden joins her siblings, sister Sterling and brother Bronze, as dad attempts to complete an historic Super Bowl three-peat. Sterling turns 4 next month; Bronze celebrated his second birthday in ...

(RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal ...